Likewise, the ACS recommends discussing PSA testing (but not necessarily offering PSA testing) to men aged 50 and above with average risk, men aged 45 and above who are African American or have a first-degree relative diagnosed with prostate cancer below 65, or men aged 40 with multiple first-degree relatives with early PC diagnoses. This evidence concerns the gene KLK3 and prostate carcinoma.